USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
A Product and Pipeline Analysis of the Global Immunoglobulin Market
A Product and Pipeline Analysis of the Global Immunoglobulin Market
Trends in Communicable and Non-Communicable Diseases Drug Pipeline
30-Sep-2015
Global
$4,950.00
Special Price $3,712.50 save 25 %
Description
Immunoglobulin therapies are life-saving medicines that have been in use for more than 60 years. They provide the patient with a variety of antibodies and are often used as a last line of defense in many severe inflammatory diseases. In some conditions, they are life-saving. However, immunoglobulin therapies are expensive. Despite this, global demand for immunoglobulin is growing and the market is expected to foresee increased competition. As of 2015, more than 40 immunoglobulin treatments have been approved, with another 28 in various stages of development. This research service provides an overview of the marketed products and those in the pipeline. The analysis divides these treatments by the communicable and non-communicable diseases that they treat. In addition, key products and companies are profiled.
Table of Contents
Key Findings
Key Findings (continued)
Major Milestones
Major Milestones (continued)
Scope of the Study
Immunoglobulin Overview
Classification of Immunoglobulins
Classification of Immunoglobulins (continued)
Treatment Guidelines
Treatment Guidelines (continued)
Market Overview
Market Overview (continued)
Market Overview (continued)
Overview of Drugs
Overview of Drugs (continued)
Competitive Landscape—Communicable Diseases Treatments
Competitive Landscape—Non-Communicable Diseases Treatments
Communicable Diseases Product Overview
Marketed Product Analysis
Marketed Product Analysis (continued)
Marketed Product Analysis (continued)
Marketed Product Analysis (continued)
Marketed Product Analysis (continued)
Marketed Product Analysis (continued)
Pipeline Product Analysis
Pipeline Product Analysis (continued)
Non-Communicable Diseases Product Overview
Marketed Product Analysis
Marketed Product Analysis (continued)
Marketed Product Analysis (continued)
Pipeline Product Analysis
Pipeline Product Analysis (continued)
Hizentra—CSL Behring
Civacir—Biotest
Flebogamma 10%—Grifols
GAMUNEX-C—Grifols
Privigen—CSL Behring
VariZIG—Cangene
Hepabulin IV—SK Holdings
Zutectra—Biotest
HyperTET—Grifols
Baxter International Inc.
Biotest AG
China Biologics Products, Inc.
CSL Behring Limited
Grifols
Octapharma AG
Kedrion Biopharma
Estimated Key Product Launch Timeline
Approval Dates
Conclusions—Future of Immunoglobulin Market
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
| No Index | No |
|---|---|
| Podcast | No |
| Author | Aish Vivekanadan |
| WIP Number | P8C1-01-00-00-00 |
| Keyword 1 | Global Immunoglobulin |
| Keyword 2 | Pipeline Analysis of the Immunoglobulin |
| Keyword 3 | Immunoglobulin Products |
| Is Prebook | No |